Ziprasidone and the activity of cytochrome P450 2D6 in healthy extensive metabolizers

British Journal of Clinical Pharmacology

Volumn 49, Issue SUPPL. 1, 2000, Pages 43-47

  Wilner, K D ^a   Demattos, S B ^a   Anziano, R J ^a   Apseloff, G ^b   Gerber, N ^b  

^a PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United States)

^b THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Dextromethorphan; Dextrorphan; Metabolism; Paroxetine; Pharmacokinetics; Ziprasidone

Indexed keywords

CYTOCHROME P450 2D6; CYTOCHROME P450 ISOENZYME; DEXTROMETHORPHAN; PAROXETINE; UNCLASSIFIED DRUG; ZIPRASIDONE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG METABOLISM; DRUG URINE LEVEL; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0034098206     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2125.2000.00152.x     Document Type: Article

References (18)

1. Prakash C, Kamel A, Cui D, et al. Identification of the major human liver cytochrome P450 isoform responsible for the primary metabolites of ziprasidone and prediction of possible drug interactions. Br J Clin Pharmacol 2000; 49(Suppl. 1): 35S-42S.
2. Meyer MC, Baldessarini RJ, Goff DC, et al. Clinically significant interactions of psychotropic agents with antipsychotic drugs. Drug Safety 1996; 15: 333-436.
3. Lane RM. Pharmacokinetic drug interaction potential of selective serotonin reuptake inhibitors. Int Clin Psychopharmacol 1996; 11(Suppl 5): 31-61.
4. Spatzenegger M, Jaegger W. Clinical importance of hepatic cytochrome P450 in drug metabolism. Drug Metab Rev 1995; 27: 397-417.
5. Ereshefsky LE, Riesenman C, Lam YWF. Antidepressant drug interactions and the cytochrome P450 system; the role of CYP 2D6. Clin Pharmacokinet 1995; 29(Suppl): 10-19.
6. Jacqz-Aigran E, Funck-Bretano C, Cresteil T. CYP2D6 and CYP3A dependent metabolism of dextromethorphan in humans. Pharmacogenetics 1993; 3: 197-204.
7. Riesenman CL, Lam YWF, Ereshefsky L. Intraindividual variability of the dextromethorphan-dextrorphan ratio in extensive metabolizers. Pharmacol Ther 1996; 59: 137.
8. Centorrhino F, Baldessarini RJ, Frankenberg FR, et al. Serotonin reuptake inhibitors alter metabolism of clozapine. Am J Psychiatry 1996; 153: 820-822.
9. Centorrhino F, Baldessarini RJ, Kando J, et al. Clozapine and metabolites: serum concentrations and clinical findings during treatment of chronically psychotic patients. J Clin Psychopharmacol 1994; 4: 119-125.
10. Metropolitan height and weight tables. Stat Bull Metrop Life Found 1983; 64: 3-9.
11. Janiszewski JS, Fouda HG, Cole RO. Development and validation of a high-sensitivity assay for an antipsychotic agent, CP-88,059, with solid-phase extraction and narrow-bore high-performance liquid chromatography. J Chromatogr 1995; 668: 133-139.
12. Brett MA, Diendorf H-D. Determination of paroxetine in human plasma using high performance liquid chromatography with fluorescence detection. J Chromatogr 1987; 419: 438-444.
13. Wenk M, Todesco L, Keller B, et al. Determination of dextromethorphan and dextrorphan in urine by high performance liquid chromatography after solid-phase extraction. J Pharmaceut Biomed Anal 1991; 9: 341-344.
14. Miceli JJ, Wilner KD, Hansen RA. Single- and multiple-dose pharmacokinetics of ziprasidone under non-fasting conditions in healthy male volunteers. Br J Clin Pharmacol 2000; 49(Suppl. 1): 5S-13S.
15. Wilner KD, Tensfeldt TG, Baris B, et al. Single- and multiple-dose pharmacokinetics of ziprasidone in healthy young and elderly volunteers. Br J Clin Pharmacol 2000; 49(Suppl. 1): 15S-20S.
16. Kaye CW, Haddock RE, Langley PF, et al. A review of the metabolism and pharmacokinetics of paroxetine in man. Acta Psychiatr Scand 1989; 80(Suppl 350): 60-75.
17. Howard HR, Prakash C, Seeger TF. Ziprasidone hydrochloride. Drugs Future 1994; 19: 560-563.
18. Tandon R, Harrigan E, Zorn SH, et al. Ziprasidone: a novel antipsychotic with unique pharmacology and therapeutic potential. J Serotonin Res 1997; 4: 159-177.